Analysis of small RNAs with the Agilent 2100 Bioanalyzer

نویسنده

  • Tobias Preckel
چکیده

Isolation of pure and intact RNA is essential, but the concentration and integrity of total RNA preparations is affected by the purification process used. Applications for which RNA will ultimately be used may include reverse transcriptase (RT)-PCR, preparations of targets for microarrays, ribonuclease protection assays, preparations of cDNA libraries and northern blotting. Recently, the importance of low-molecular-weight (LMW) RNAs, such as small interfering RNAs (siRNAs) and small nuclear RNAs (snRNAs), has been outlined in different studies1. In particular, the importance of a new class of small RNA, microRNAs (miRNAs), has been highlighted. Each miRNA is thought to regulate multiple genes, and as hundreds of miRNA genes are predicted to be present in higher eukaryotes, the potential regulatory circuitry afforded by them is enormous. Standard protocols for the isolation of total RNA and mRNA are not optimized for recovering small RNA molecules and may lead to major loss of miRNAs and other small RNAs. Therefore, an efficient, accurate method is needed to determine the integrity and the concentration of total and small RNAs from various sources. The Agilent 2100 Bioanalyzer offers such advantages, coupled with a rapid, automated system (Vitale, D. Comparing performance of the Agilent 2100 Bioanalyzer to traditional RNA analysis techniques. Agilent publication 5980-2206E; 2002; Lightfoot, S. Quantitation comparison of total RNA using the Agilent 2100 Bioanalyzer, ribogreen analysis and UV spectrometry. Agilent publication 5988-7650EN; 2003; Kuschel, M. Analysis of total RNA with the Agilent 2100 Bioanalyzer. Agilent publication 5968-7493E; 2001).

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Analysis of small RNAs from Drosophila Schneider cells using the Small RNA assay on the Agilent 2100 bioanalyzer

Over the past ten years, the importance of diverse classes of small noncoding RNA molecules has increasingly been recognized. To study all these newly discovered regulatory RNAs, it has been necessary to improve existing technologies or to develop new ones. The Agilent 2100 bioanalyzer was used with the recently available Agilent Small RNA assay to analyze and monitor microRNA enrichment in Dro...

متن کامل

Analysis of small RNAs with the Agilent 2100 bioanalyzer

The Total RNA 6000 Nano Kit was used with the Agilent 2100 bioanalyzer to determine the integrity and the concentration of small RNA (i.e., 5.8S, 5S RNAs and tRNA) samples extracted with different protocols from various cell lines. The small RNAs fraction (<200 bp) should also contain microRNAs in their primitive (pri-miRNA), precursor (premiRNA) and mature (miRNA) forms. The data analysis soft...

متن کامل

Monitoring extraction efficiency of small RNAs with the Agilent 2100 Bioanalyzer and the Small RNA Kit

High quality small RNA extraction is a critical aspect in miRNA expression profiling. Various RNA isolation methods using commercially available kits can extract total RNA enriched for small RNA. However, each of these protocols yields small RNA preparations that can differ in total quantity and quality, which may affect downstream experiments. This Application Note demonstrates the use of the ...

متن کامل

Analysis of miRNA content in total RNA preparations using the Agilent 2100 bioanalyzer

Advances in miRNA research have led to the increased demand for techniques appropriate for the analysis of this small RNA subclass. This Application Note describes the use of the Small RNA assay with the Agilent 2100 bioanalyzer to quickly and efficiently analyze and monitor miRNA content in total RNA samples. Catherine Tissot Application Note Analysis of miRNA content in total RNA preparations...

متن کامل

Detection of DNA mutations associated with mitochondrial diseases by Agilent 2100 bioanalyzer.

BACKGROUND Molecular analysis of mitochondrial DNA (mtDNA) has provided a final diagnosis for many of the mitochondrial diseases. We evaluated the Agilent 2100 bioanalyzer (Agilent Technologies, Palo Alto, CA) to determine whether the system could replace the conventional restriction fragment length polymorphism (RFLP) analysis by the agarose gel electrophoresis for the detection of the mtDNA m...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2006